Schizophrenia Research
Volume 115, Issue 2 , Pages 191-201 , December 2009

Specific brain structural abnormalities in first-episode schizophrenia. A comparative study with patients with schizophreniform disorder, non-schizophrenic non-affective psychoses and healthy volunteers.

  • Benedicto Crespo-Facorro

      Affiliations

    • University Hospital Marqués de Valdecilla, CIBERSAM, Department of Psychiatry, School of Medicine, University of Cantabria, Santander, Spain
    • Corresponding Author InformationCorresponding author. Hospital Universitario Marqués de Valdecilla, Department of Psychiatry, Planta 2a, Edificio 2 de Noviembre, Avda. Valdecilla s/n, 39008, Santander, Spain. Tel.: +34 942 202537; fax: +34 942 203447.
    • These authors contributed equally to this project and should be considered co-first authors.
    • ,
  • Roberto Roiz-Santiáñez

      Affiliations

    • University Hospital Marqués de Valdecilla, CIBERSAM, Department of Psychiatry, School of Medicine, University of Cantabria, Santander, Spain
    • These authors contributed equally to this project and should be considered co-first authors.
    • ,
  • Rocío Pérez-Iglesias

      Affiliations

    • University Hospital Marqués de Valdecilla, CIBERSAM, Department of Psychiatry, School of Medicine, University of Cantabria, Santander, Spain
    • ,
  • Diana Tordesillas-Gutiérrez

      Affiliations

    • University Hospital Marqués de Valdecilla, CIBERSAM, Department of Psychiatry, School of Medicine, University of Cantabria, Santander, Spain
    • ,
  • Ignacio Mata

      Affiliations

    • University Hospital Marqués de Valdecilla, CIBERSAM, Department of Psychiatry, School of Medicine, University of Cantabria, Santander, Spain
    • ,
  • José Manuel Rodríguez-Sánchez

      Affiliations

    • University Hospital Marqués de Valdecilla, CIBERSAM, Department of Psychiatry, School of Medicine, University of Cantabria, Santander, Spain
    • ,
  • Enrique Marco de Lucas

      Affiliations

    • University Hospital Marqués de Valdecilla, Department of Neuroradiology, Santander, Spain
    • ,
  • José Luis Vázquez-Barquero

      Affiliations

    • University Hospital Marqués de Valdecilla, CIBERSAM, Department of Psychiatry, School of Medicine, University of Cantabria, Santander, Spain

Received 15 June 2009 ,Revised 26 August 2009 ,Accepted 7 September 2009.

References 

  1. Andreasen NC. The Scale for the Assesment of Negative Symptoms (SANS). Iowa City: University of Iowa; 1983;
  2. Andreasen NC. The Scale for the Assesment of Positive Symptoms (SAPS). Iowa City: University of Iowa; 1984;
  3. Andreasen NC, Cohen G, Harris G, Cizadlo T, Parkkinen J, Rezai K, et al. Image processing for the study of brain structure and function: problems and programs. J. Neuropsychiatr. Clin. Neurosci. 1992;4(2):125–133
  4. Andreasen NC, Flaum M, Arndt S. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch. Gen. Psychiatry. 1992;49(8):615–623
  5. Andreasen NC, Arndt S, Swayze V, Cizadlo T, Flaum M, O'Leary D, et al. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science. 1994;266(5183):294–298
  6. Barkovich AJ. Malformations of neocortical development: magnetic resonance imaging correlates. Curr. Opin. Neurol. 1996;9(2):118–121
  7. Cahn W, Hulshoff Pol HE, Bongers M, Schnack HG, Mandl RC, Van Haren NE, et al. Brain morphology in antipsychotic-naive schizophrenia: a study of multiple brain structures. Br. J. Psychiatry Suppl. 2002;43:s66–s72
  8. Cannon TD, van Erp TG, Huttunen M, Lonnqvist J, Salonen O, Valanne L, et al. Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls. Arch. Gen. Psychiatry. 1998;55(12):1084–1091
  9. Chakos MH, Lieberman JA, Bilder RM, Borenstein M, Lerner G, Bogerts B, et al. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am. J. Psychiatry. 1994;151(10):1430–1436
  10. Corson PW, Nopoulos P, Andreasen NC, Heckel D, Arndt S. Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network. Biol. Psychiatry. 1999;46(5):712–720
  11. Courchesne E, Chisum HJ, Townsend J, Cowles A, Covington J, Egaas B, et al. Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers. Radiology. 2000;216(3):672–682
  12. Crespo-Facorro B, Perez-Iglesias R, Ramirez-Bonilla M, Martinez-Garcia O, Llorca J, Luis Vazquez-Barquero J. A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis. J. Clin. Psychiatry. 2006;67(10):1511–1521
  13. Crespo-Facorro B, Roiz-Santianez R, Pelayo-Teran JM, Gonzalez-Blanch C, Perez-Iglesias R, Gutierrez A, et al. Caudate nucleus volume and its clinical and cognitive correlations in first episode schizophrenia. Schizophr. Res. 2007;91(1–3):87–96
  14. Crespo-Facorro B, Roiz-Santianez R, Pelayo-Teran JM, Rodriguez-Sanchez JM, Perez-Iglesias R, Gonzalez-Blanch C, et al. Reduced thalamic volume in first-episode non-affective psychosis: correlations with clinical variables, symptomatology and cognitive functioning. NeuroImage. 2007;35(4):1613–1623
  15. Crespo-Facorro B, Roiz-Santianez R, Perez-Iglesias R, Pelayo-Teran JM, Rodriguez-Sanchez JM, Tordesillas-Gutierrez D, et al. Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2008;32(8):1936–1943
  16. Crow TJ. Nature of the genetic contribution to psychotic illness — a continuum viewpoint. Acta Psychiatr. Scand. 1990;81(5):401–408
  17. Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch. Gen. Psychiatry. 2003;60(5):443–456
  18. DeLisi LE, Hoff AL, Schwartz JE, Shields GW, Halthore SN, Gupta SM, et al. Brain morphology in first-episode schizophrenic-like psychotic patients: a quantitative magnetic resonance imaging study. Biol. Psychiatry. 1991;29(2):159–175
  19. DeLisi LE, Tew W, Xie S, Hoff AL, Sakuma M, Kushner M, et al. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings. Biol. Psychiatry. 1995;38(6):349–360
  20. Dickey CC, McCarley RW, Shenton ME. The brain in schizotypal personality disorder: a review of structural MRI and CT findings. Harv. Rev. Psychiatr. 2002;10(1):1–15
  21. Ellison-Wright I, Glahn DC, Laird AR, Thelen SM, Bullmore E. The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am. J. Psychiatry. 2008;165(8):1015–1023
  22. Ettinger U, Picchioni M, Landau S, Matsumoto K, van Haren NE, Marshall N, et al. Magnetic resonance imaging of the thalamus and adhesio interthalamica in twins with schizophrenia. Arch. Gen. Psychiatry. 2007;64(4):401–409
  23. First MB, S. R, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV-TR Axis I Disorders-Non patient Edition. New York: New York State Psychiatric Institute; 2001;
  24. Gallinat J, Meisenzahl E, Jacobsen LK, Kalus P, Bierbrauer J, Kienast T, et al. Smoking and structural brain deficits: a volumetric MR investigation. Eur. J. NeuroSci. 2006;24(6):1744–1750
  25. Gilbert AR, Rosenberg DR, Harenski K, Spencer S, Sweeney JA, Keshavan MS. Thalamic volumes in patients with first-episode schizophrenia. Am. J. Psychiatry. 2001;158(4):618–624
  26. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry. 2003;160(4):636–645
  27. Gunduz H, Wu H, Ashtari M, Bogerts B, Crandall D, Robinson DG, et al. Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects. Biol. Psychiatry. 2002;51(10):801–808
  28. Gur RE, Maany V, Mozley PD, Swanson C, Bilker W, Gur RC. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am. J. Psychiatry. 1998;155(12):1711–1717
  29. Gur RE, Turetsky BI, Bilker WB, Gur RC. Reduced gray matter volume in schizophrenia. Arch. Gen. Psychiatry. 1999;56(10):905–911
  30. Ho BC, Alicata D, Ward J, Moser DJ, O'Leary DS, Arndt S, et al. Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. Am. J. Psychiatry. 2003;160(1):142–148
  31. Ho BC, Alicata D, Mola C, Andreasen NC. Hippocampus volume and treatment delays in first-episode schizophrenia. Am. J. Psychiatry. 2005;162(8):1527–1529
  32. Hoff AL, Sakuma M, Razi K, Heydebrand G, Csernansky JG, DeLisi LE. Lack of association between duration of untreated illness and severity of cognitive and structural brain deficits at the first episode of schizophrenia. Am. J. Psychiatry. 2000;157(11):1824–1828
  33. Honea R, Crow TJ, Passingham D, Mackay CE. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am. J. Psychiatry. 2005;162(12):2233–2245
  34. Honea RA, Meyer-Lindenberg A, Hobbs KB, Pezawas L, Mattay VS, Egan MF, et al. Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblings. Biol. Psychiatry. 2008;63(5):465–474
  35. Jernigan TL, Butters N, DiTraglia G, Schafer K, Smith T, Irwin M, et al. Reduced cerebral grey matter observed in alcoholics using magnetic resonance imaging. Alcohol. Clin. Exp. Res. 1991;15(3):418–427
  36. Johnstone EC, Owens DG, Crow TJ, Frith CD, Alexandropolis K, Bydder G, et al. Temporal lobe structure as determined by nuclear magnetic resonance in schizophrenia and bipolar affective disorder. J. Neurol. Neurosurg. Psychiatry. 1989;52(6):736–741
  37. Jones BE, Yang TZ. The efferent projections from the reticular formation and the locus coeruleus studied by anterograde and retrograde axonal transport in the rat. J. Comp. Neurol. 1985;242(1):56–92
  38. Keshavan MS, Rosenberg D, Sweeney JA, Pettegrew JW. Decreased caudate volume in neuroleptic-naive psychotic patients. Am. J. Psychiatry. 1998;155(6):774–778
  39. Konick LC, Friedman L. Meta-analysis of thalamic size in schizophrenia. Biol. Psychiatry. 2001;49(1):28–38
  40. Koo MS, Dickey CC, Park HJ, Kubicki M, Ji NY, Bouix S, et al. Smaller neocortical gray matter and larger sulcal cerebrospinal fluid volumes in neuroleptic-naive women with schizotypal personality disorder. Arch. Gen. Psychiatry. 2006;63(10):1090–1100
  41. Lang DJ, Kopala LC, Vandorpe RA, Rui Q, Smith GN, Goghari VM, et al. An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone. Am. J. Psychiatry. 2001;158(4):625–631
  42. Lawrie SM, Abukmeil SS. Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br. J. Psychiatry. 1998;172:110–120
  43. Lawrie SM, Whalley HC, Abukmeil SS, Kestelman JN, Donnelly L, Miller P, et al. Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophrenia. Biol. Psychiatry. 2001;49(10):811–823
  44. Lim KO, Sullivan EV, Zipursky RB, Pfefferbaum A. Cortical gray matter volume deficits in schizophrenia: a replication. Schizophr. Res. 1996;20(1–2):157–164
  45. Magnotta VA, Harris G, Andreasen NC, O'Leary DS, Yuh WT, Heckel D. Structural MR image processing using the BRAINS2 toolbox. Comput. Med. Imaging Graph. 2002;26(4):251–264
  46. McDonald C, Bullmore ET, Sham PC, Chitnis X, Wickham H, Bramon E, et al. Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch. Gen. Psychiatry. 2004;61(10):974–984
  47. McDonald C, Bullmore E, Sham P, Chitnis X, Suckling J, MacCabe J, et al. Regional volume deviations of brain structure in schizophrenia and psychotic bipolar disorder: computational morphometry study. Br. J. Psychiatry. 2005;186:369–377
  48. McDonald C, Marshall N, Sham PC, Bullmore ET, Schulze K, Chapple B, et al. Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives. Am. J. Psychiatry. 2006;163(3):478–487
  49. Murray RM, Sham P, Van Os J, Zanelli J, Cannon M, McDonald C. A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr. Res. 2004;71(2–3):405–416
  50. Nakamura M, Salisbury DF, Hirayasu Y, Bouix S, Pohl KM, Yoshida T, et al. Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study. Biol. Psychiatry. 2007;62(7):773–783
  51. Narr KL, Sharma T, Woods RP, Thompson PM, Sowell ER, Rex D, et al. Increases in regional subarachnoid CSF without apparent cortical gray matter deficits in schizophrenia: modulating effects of sex and age. Am. J. Psychiatry. 2003;160(12):2169–2180
  52. Narr KL, Bilder RM, Kim S, Thompson PM, Szeszko P, Robinson D, et al. Abnormal gyral complexity in first-episode schizophrenia. Biol. Psychiatry. 2004;55(8):859–867
  53. Narr KL, Bilder RM, Woods RP, Thompson PM, Szeszko P, Robinson D, et al. Regional specificity of cerebrospinal fluid abnormalities in first episode schizophrenia. Psychiatry Res. 2006;146(1):21–33
  54. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 1971;9(1):97–113
  55. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol. Rep. 1962;10:799–812
  56. Prasad KM, Keshavan MS. Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct “extended endophenotypes”?. Schizophr. Bull. 2008;34(4):774–790
  57. Preuss UW, Zetzsche T, Jager M, Groll C, Frodl T, Bottlender R, et al. Thalamic volume in first-episode and chronic schizophrenic subjects: a volumetric MRI study. Schizophr. Res. 2005;73(1):91–101
  58. Salgado-Pineda P, Baeza I, Perez-Gomez M, Vendrell P, Junque C, Bargallo N, et al. Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients. NeuroImage. 2003;19(2 Pt 1):365–375
  59. Schulze KK, Hall MH, McDonald C, Marshall N, Walshe M, Murray RM, et al. P50 auditory evoked potential suppression in bipolar disorder patients with psychotic features and their unaffected relatives. Biol. Psychiatry. 2007;62(2):121–128
  60. Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophr. Res. 2001;49(1–2):1–52
  61. Steen RG, Mull C, McClure R, Hamer RM, Lieberman JA. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br. J. Psychiatry. 2006;188:510–518
  62. Strasser HC, Lilyestrom J, Ashby ER, Honeycutt NA, Schretlen DJ, Pulver AE, et al. Hippocampal and ventricular volumes in psychotic and nonpsychotic bipolar patients compared with schizophrenia patients and community control subjects: a pilot study. Biol. Psychiatry. 2005;57(6):633–639
  63. Swayze VW, Andreasen NC, Alliger RJ, Ehrhardt JC, Yuh WT. Structural brain abnormalities in bipolar affective disorder. Ventricular enlargement and focal signal hyperintensities. Arch. Gen. Psychiatry. 1990;47(11):1054–1059
  64. Tauscher-Wisniewski S, Tauscher J, Christensen BK, Mikulis DJ, Zipursky RB. Volumetric MRI measurement of caudate nuclei in antipsychotic-naive patients suffering from a first episode of psychosis. J. Psychiatr. Res. 2005;39(4):365–370
  65. Vita A, De Peri L, Silenzi C, Dieci M. Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr. Res. 2006;82(1):75–88
  66. Ward KE, Friedman L, Wise A, Schulz SC. Meta-analysis of brain and cranial size in schizophrenia. Schizophr. Res. 1996;22(3):197–213
  67. White T, Andreasen NC, Nopoulos P, Magnotta V. Gyrification abnormalities in childhood- and adolescent-onset schizophrenia. Biol. Psychiatry. 2003;54(4):418–426
  68. Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET. Meta-analysis of regional brain volumes in schizophrenia. Am. J. Psychiatry. 2000;157(1):16–25
  69. Yucel M, Solowij N, Respondek C, Whittle S, Fornito A, Pantelis C, et al. Regional brain abnormalities associated with long-term heavy cannabis use. Arch. Gen. Psychiatry. 2008;65(6):694–701
  70. Zipursky RB, Marsh L, Lim KO, DeMent S, Shear PK, Sullivan EV, et al. Volumetric MRI assessment of temporal lobe structures in schizophrenia. Biol. Psychiatry. 1994;35(8):501–516
  71. Zipursky RB, Lambe EK, Kapur S, Mikulis DJ. Cerebral gray matter volume deficits in first episode psychosis. Arch. Gen. Psychiatry. 1998;55(6):540–546

PII: S0920-9964(09)00426-5

doi: 10.1016/j.schres.2009.09.007

Schizophrenia Research
Volume 115, Issue 2 , Pages 191-201 , December 2009

Article Tools

* Image Usage & Resolution